Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

You are here: Home » News & Analysis

News & Analysis

Print

China biotech company and industry news and analysis...

Recent Articles

  JHL Forms $257 Million Partnership with Sanofi for Rituximab Biosimilar
  Luye Closes $269 Million Acquisition of Swiss Pharma's Patch Business
  Uni-Bio and Beijing Sun-Novo to Co-Develop Diabetes Treatments
  Beijing's Novogene Closes $75 Million B Round for Genomic Sequencing
  Alphamab/3D Medicines PD-L1 Antibody Approved for US Trial
  dMed, a Collaborative Shanghai CRO Consulting Startup, Lands $8 Million
  MicuRx Tests Oral/IV Versions of its Anti-Infective in US Trial
  Innovent Biologics Raises $260 Million in D Round, Setting a Record
  WI Harper and Partners to Form New US-China Early Stage VC Fund
  Boehringer Forms Stem Cell Collaboration with China Southeast University
 
Login